Stay updated on ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Sign up to get notified when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.

Latest updates to the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (v3.4.3) was added to the record history, replacing the previous revision (v3.4.2).SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new system revision entry (Revision: v3.4.2) has been added. The older funding-notice banner and Revision: v3.4.1 have been removed.SummaryDifference0.6%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and the NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check48 days agoChange DetectedThe changes are cosmetic updates to the history display, including a glossary, color-coded highlights, and revision banners, with capitalization adjusted in 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check62 days agoChange DetectedThe record history shows Revision: v3.3.4 replacing Revision: v3.3.3, indicating a small update to the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedNew Revision: v3.3.3 appears in the record history. The footer/history no longer shows 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.2%

Stay in the know with updates to ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.